Aquilo Capital Management LLC 13D and 13G filings for Pieris Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 4:37 pm Sale |
2023-12-31 | 13G | Pieris Pharmaceuticals, Inc. PIRS |
Aquilo Capital Management LLC | 14,085 1.100% |
-56,911 (-80.16%) |
Filing |
| 2023-02-14 11:28 am Purchase |
2022-12-31 | 13G | Pieris Pharmaceuticals, Inc. PIRS |
Aquilo Capital Management LLC | 70,995 7.500% |
16,954 (+31.37%) |
Filing |
| 2022-02-14 3:20 pm Sale |
2021-12-31 | 13G | Pieris Pharmaceuticals, Inc. PIRS |
Aquilo Capital Management LLC | 54,041 5.900% |
-5,988 (-9.97%) |
Filing |
| 2021-02-16 4:13 pm Sale |
2020-12-31 | 13G | Pieris Pharmaceuticals, Inc. PIRS |
Aquilo Capital Management LLC | 60,029 8.400% |
-9,665 (-13.87%) |
Filing |